Skip to content
All resources

Testing, quality and handling

Research Use Only (RUO) Meaning: What the Label Says and What It Doesn't

AR

By

· 9 min read

A summary of published research, with citations. It states no amount, schedule or route, and makes no claim about what this compound does in a person. Supplied for laboratory research use only.

On this page · 7 sections
  1. Where does the RUO label come from?
  2. How does RUO differ from IVD labelling and drug authorisation?
  3. Is "research use only" a legal exemption for peptides?
  4. Is "research grade" a quality grade?
  5. What does an RUO label not certify?
  6. How should RUO materials be documented in a laboratory?
  7. Frequently asked questions

"Research use only" (RUO) means a product is supplied for laboratory research and has not been authorised for any clinical, diagnostic or human use. It is a statement about intended use, not about quality. RUO material has not been reviewed by a regulator, is not made under drug manufacturing rules and carries no performance claims. Health Canada also says the label is not a legal shield: for peptides, a research use label "does not make a product legal to import or sell in Canada."

A single reagent vial with a plain label on a laboratory bench, between an open lab notebook and a receiving-log clipboard
Illustration: a reagent, its notebook and its receiving log.

Where does the RUO label come from?

The label comes from the regulation of laboratory reagents and diagnostic devices, where it has a defined role. Health Canada's guidance on classifying in vitro diagnostic devices (IVDDs) gives the core rule. An IVDD labelled "For Research Use Only" is exempt from the Medical Devices Regulations, but only if the manufacturer does not label or present it for a specific diagnostic use, does not label it with specific performance characteristics, and does not supply a bibliography pointing to a specific diagnostic application.

Health Canada's notice on research use only labelling, issued in 2021 for COVID-19 tests, spells out what that means. RUO labelling "applies to a medical device in the laboratory research phase of development." A product cannot honestly carry it if it has validated performance characteristics, instructions citing performance claims, or is under regulatory review. A device labelled RUO when it was imported and sold cannot then be used for clinical diagnosis, screening or surveillance, even if it is authorised later. Health Canada decides whether a product really meets the RUO criteria from all the evidence, including marketing material. If it does not, Health Canada treats it as having been imported, advertised or sold without authorisation.

So even in the field where RUO is a recognised category, it is a narrow exemption that depends on the product being, and being presented as, a research tool.

How does RUO differ from IVD labelling and drug authorisation?

Label or statusWhat it meansWho reviewed it
For research use onlySupplied for laboratory research; no clinical, diagnostic or human use; no performance claimsNobody, as a condition of sale
Investigational use onlyFor use in an authorised clinical study of the productThe regulator authorises the study, not the product
For in vitro diagnostic useA licensed diagnostic device with stated performanceHealth Canada, under the Medical Devices Regulations
Authorised drug (DIN)A specific product authorised for stated uses in stated patientsHealth Canada, for safety, efficacy and quality

The table shows how much the RUO row lacks. An IVD label means a regulator has seen evidence that the test does what it claims. A DIN means a regulator has reviewed a specific manufacturer's product, made under an establishment licence to a filed specification. RUO means none of those reviews took place. How Health Canada regulates drugs covers the DIN side in more detail.

Health Canada says no. Its peptides research page, updated on 23 October 2026, says it has seen peptide products labelled "Research Use Only" or "Investigational Use Only" that are not authorised for human use. It says "a research use label does not make a product legal to import or sell in Canada", and that such products "are subject to Canadian regulatory requirements and to our compliance and enforcement activities." Its April 2026 public advisory on unauthorized peptides says the same about products marketed "For Research Use Only – Not for Human Consumption", and tells consumers not to buy or use them.

This follows from how the Food and Drugs Act defines a drug. The definition covers substances "manufactured, sold or represented for use in" treating disease or modifying organic functions. How a product is made, sold and presented counts, not only its label. The IVD guidance makes the same point about devices: Health Canada looks at marketing material and the circumstances of sale to decide whether the label is honest. Health Canada's GLP-1 warnings covers the advisories.

Is "research grade" a quality grade?

No. RUO and "research grade" describe what a product is supplied for. They say nothing about how well it was made. Some grade terms do have outside definitions. A pharmacopoeial grade means the material meets a published monograph, and a GMP-manufactured product was made under good manufacturing practice. RUO has no shared specification behind it. Two RUO vials of the same peptide from two suppliers can differ in purity, salt form, water content, net peptide content and endotoxin, and the label shows none of that.

The literature on research reagents shows what happens when a label is taken for proof. In antibody research, one widely cited review noted that for commercial antibodies "what is on the label does not necessarily correspond to what is in the tube", and argued that each reagent must be validated for the specific use it is put to (PMID 20359301). An international working group later proposed five ways to validate an antibody for a given application (PMID 27595404). For synthetic peptides specifically:

  • Cross-contamination. Peptide libraries bought from two custom suppliers contained contaminating peptides that produced false-positive T-cell responses. In one case the contaminant made up about 1 percent of the sample by weight (PMID 18077621).
  • Counter-ions. Trifluoroacetate, left behind by HPLC purification, reduced cell proliferation in osteoblast and chondrocyte cultures at very low concentrations. With some peptides this was enough to hide a real effect, or to make one appear that was not there (PMID 10567002). TFA versus acetate salts covers the chemistry.

Neither problem shows up on a label. Both show up only in analysis, which is why the certificate matters more than the label.

What does an RUO label not certify?

Spelled out, an RUO label does not tell you:

  • that the material is what the label names (identity needs mass spectrometry or an equivalent method)
  • how pure it is, or what the impurities are
  • how much peptide the vial actually holds, as opposed to salt and water (net content versus purity)
  • endotoxin or bioburden levels
  • that it was made under GMP or any inspected quality system
  • that any regulator has reviewed it for any purpose
  • that it is legal to import or sell in a particular jurisdiction

Some of these gaps can be closed with documents. A certificate of analysis from a named laboratory, for a stated lot, can show identity, purity and sometimes content and endotoxin for that sample. What a certificate of analysis establishes covers what each section proves. The certificates this site holds are listed on its lab results page, and the same questions apply to them. Documents cannot close the regulatory gaps. A certificate is not an authorisation.

How should RUO materials be documented in a laboratory?

Because the label guarantees so little, the laboratory's own records are what hold the work together. A workable minimum for each RUO reagent:

  1. Identify the exact material. Supplier, catalogue name, lot number, and the date received. For antibodies, cell lines and software, journals that take part in the Resource Identification Initiative ask for a unique identifier, so other groups can find the same resource (PMID 26594330). For a synthetic peptide, the lot number and its certificate do that job.
  2. File the certificate against the lot. Note what it measured and what it left out. A certificate for a different lot is not evidence about yours.
  3. Record how it arrived and how it was stored. Note the condition on receipt, whether the cold packs were still cold, the storage location and temperature, and every change of state. Peptide shipping and temperature covers what transit can do to a sample.
  4. Validate it for the use it is put to. Run a positive control, a vehicle control and, where it matters, a check of identity or activity.
  5. Report it in methods. Supplier, lot, salt form and any in-house analysis. A methods section that only says "purchased from a commercial supplier" cannot be reproduced.
  6. Keep the use within the label. Institutional approvals, biosafety and animal care committees and the rules in Health Canada's peptide pages still apply. RUO material is never for use in people.

Nothing here is medical, dosing, or therapeutic guidance.

Frequently asked questions

What does RUO stand for? Research use only. It marks a product supplied for laboratory research that has not been authorised or validated for clinical, diagnostic or human use. In Health Canada's diagnostic device guidance, RUO labelling is meant for products in the laboratory research phase of development that carry no diagnostic claims or performance characteristics.

Is RUO the same as "not for human consumption"? They overlap but are not the same. RUO states the intended use. "Not for human consumption" is a warning. Health Canada's April 2026 advisory addressed products carrying both phrases and said neither makes a product legal or exempt from regulatory requirements. Neither phrase says anything about quality.

Can RUO reagents be used for clinical testing? Not as RUO products. Health Canada's guidance states that a device labelled RUO when it was imported and sold cannot be used for clinical diagnosis, screening or surveillance, even if it is authorised later. Clinical use needs an authorised product, or an authorised investigational study.

Is RUO material lower quality than GMP material? Not necessarily. An RUO reagent can be very pure. But RUO gives no assurance either way, while GMP describes a controlled, inspected manufacturing system. The only way to judge an RUO lot is by its analytical documents and your own checks.

Selected Research References

  1. Bordeaux J, Welsh A, Agarwal S, et al. Antibody validation. BioTechniques. 2010;48(3):197-209. pubmed.ncbi.nlm.nih.gov/20359301
  2. Uhlen M, Bandrowski A, Carr S, et al. A proposal for validation of antibodies. Nature Methods. 2016;13(10):823-827. pubmed.ncbi.nlm.nih.gov/27595404
  3. Currier JR, Galley LM, Wenschuh H, et al. Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessment. Clinical and Vaccine Immunology. 2008;15(2):267-276. pubmed.ncbi.nlm.nih.gov/18077621
  4. Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. American Journal of Physiology. 1999;277(5):E779-E783. pubmed.ncbi.nlm.nih.gov/10567002
  5. Bandrowski A, Brush M, Grethe JS, et al. The Resource Identification Initiative: A cultural shift in publishing. F1000Research. 2015;4:134. pubmed.ncbi.nlm.nih.gov/26594330

All products sold by NovaEvum are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease.